The 2014–2015 National Impact of the 2014 American Academy of Pediatrics Guidance for Respiratory Syncytial Virus Immunoprophylaxis on Preterm Infants Born in the United States

Eitemau Tebyg

• Respiratory Syncytial Virus Hospitalizations among U.S. Preterm Infants Compared with Term Infants Before and After the 2014 American Academy of Pediatrics Guidance on Immunoprophylaxis: 2012–2016
  gan: Goldstein, Mitchell, et al.
  Cyhoeddwyd: (2018)
• Update on respiratory syncytial virus hospitalizations among U.S. preterm and term infants before and after the 2014 American Academy of Pediatrics policy on immunoprophylaxis: 2011-2017
  gan: Fergie, Jaime, et al.
  Cyhoeddwyd: (2020)
• Respiratory syncytial virus hospitalizations in US preterm infants after the 2014 change in immunoprophylaxis guidance by the American Academy of Pediatrics
  gan: Krilov, Leonard R., et al.
  Cyhoeddwyd: (2020)
• 740. Impact of the 2014 American Academy of Pediatrics Guidance on Respiratory Syncytial Virus Hospitalization Rates for Preterm Infants <29 Weeks Gestational Age at Birth: 2012–2016
  gan: Goldstein, Mitchell, et al.
  Cyhoeddwyd: (2018)
• Modeling the Potential Impact of the 2014 American Academy of Pediatrics Respiratory Syncytial Virus Prophylaxis Guidance on Preterm Infant RSV Outcomes
  gan: McLaurin, Kimmie K., et al.
  Cyhoeddwyd: (2015)